These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1648851)

  • 1. [Protein adsorption at the tips from synthetic polymers as the cause of incorrect titer analysis of interferons in antiviral bioassays].
    Tonew M; Ohme E; Gerlach D; Wondraczek RH
    Z Med Lab Diagn; 1991; 32(2):108-13. PubMed ID: 1648851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of an antiviral activity of recombinant consensus interferon with recombinant interferon-alpha-2b.
    Koyama AH; Arakawa T; Adachi A
    Microbes Infect; 1999 Nov; 1(13):1073-7. PubMed ID: 10572309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activities of synthetic peptides of the sequence of human interferon-alpha.
    Eichmann E; Majarov VA; Kozhich AT; Noll F; Zav'yalov VP
    Immunol Lett; 1990 Jul; 24(4):233-6. PubMed ID: 2167875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing a safe, rapid, convenient and low-cost antiviral assay of interferon bioactivity based on recombinant VSV expressing GFP.
    Chen W; Wen Z; Zhang J; Li C; Huang K; Bu Z
    J Virol Methods; 2018 Feb; 252():1-7. PubMed ID: 28834736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sensitivity of different cell lines to interferons: the relative antiviral activity as a function of the interferon subtype].
    Tonew M; Glück B; Ohme E; Wondraczek RH
    J Basic Microbiol; 1989; 29(8):537-45. PubMed ID: 2559962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis C.
    Boulestin A; Kamar N; Legrand-Abravanel F; Sandres-Saune K; Alric L; Vinel JP; Rostaing L; Izopet J
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3610-2. PubMed ID: 15328140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leukocyte migration inhibiting factor in preparations of alpha and gamma interferons].
    Vakhromeeva NS; Bagaeva LV; Kuznetsov VP; Medunitsyn NV; Bobkova EV
    Vopr Virusol; 1986; 31(5):617-9. PubMed ID: 3026096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interferon sensitivity of various cell lines].
    Tonew M; Glück B
    J Basic Microbiol; 1986; 26(3):173-9. PubMed ID: 3018215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three bioassays for rat interferon.
    Burleson GR; Herzog DP
    J Virol Methods; 1984 Oct; 9(2):163-71. PubMed ID: 6210298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-induced antiviral state is inhibited by neomycin and mimicked by diacylglycerols.
    Cernescu C; Constantinescu SN; Baltă F; Popescu LM; Cajal N
    Biochem Biophys Res Commun; 1988 Feb; 151(1):402-7. PubMed ID: 2831886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Critical study of an assay of human leukocyte and lymphoblastoid interferon on MDBK cells, in microplaque, by the "dye uptake" method. I. Biological factors].
    Capellier M; Lévy-Benezra R; Poindron P
    Ann Pharm Fr; 1986; 44(3):217-27. PubMed ID: 3026225
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantification of the antiviral effect of interferon by immunoassay of vesicular stomatitis virus proteins.
    Wallach D
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2221-7. PubMed ID: 6194250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A practical cytopathic effect/dye-uptake interferon assay for routine use in the clinical laboratory.
    Yousefi S; Escobar MR; Gouldin CW
    Am J Clin Pathol; 1985 Jun; 83(6):735-40. PubMed ID: 2988328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegylation of IFN-alpha and antiviral activity.
    Boulestin A; Kamar N; Sandres-Sauné K; Alric L; Vinel JP; Rostaing L; Izopet J
    J Interferon Cytokine Res; 2006 Dec; 26(12):849-53. PubMed ID: 17238827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic activities of human interferons are mediated by multiple response pathways.
    Forti RL; Mitchell WM; Hubbard WC; Workman RJ; Forbes JT
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):170-4. PubMed ID: 6320163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon aerosol suppression of vesicular stomatitis virus replication in the lungs of infected mice.
    Wyde PR; Wilson SZ; Sun CS; Knight V
    Antimicrob Agents Chemother; 1984 Oct; 26(4):450-4. PubMed ID: 6097164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial inhibition of vesicular stomatitis virus by the interferon-induced human 9-27 protein.
    Alber D; Staeheli P
    J Interferon Cytokine Res; 1996 May; 16(5):375-80. PubMed ID: 8727077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development and use of an immunoenzyme method for detecting interferon].
    Kiktenko AV
    Vopr Virusol; 1985; 30(2):242-4. PubMed ID: 2988214
    [No Abstract]   [Full Text] [Related]  

  • 19. A recombinant human interferon-alpha B/D hybrid with a broad host-range.
    Horisberger MA; de Staritzky K
    J Gen Virol; 1987 Mar; 68 ( Pt 3)():945-8. PubMed ID: 3029315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD).
    Zhang XM; He DN; Zhou B; Pang R; Liu K; Zhao J; Chen PY
    Antiviral Res; 2013 Aug; 99(2):149-57. PubMed ID: 23727591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.